oxyphenbutazone has been researched along with Alopecia in 2 studies
Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Alopecia: Absence of hair from areas where it is normally present.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fasching, U | 1 |
Eberl, R | 1 |
Almeyda, J | 1 |
Levantine, A | 1 |
1 review available for oxyphenbutazone and Alopecia
Article | Year |
---|---|
Drug reactions. XX. Cutaneous reactions to anticonvulsants.
Topics: Adolescent; Adult; Alopecia; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dermatitis, Ex | 1972 |
1 trial available for oxyphenbutazone and Alopecia
Article | Year |
---|---|
[Sulindac: Clinical test of a new antiinflammatory agent in rheumatoid arthritis (author's transl)].
Topics: Adult; Aged; Alopecia; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Benzylidene Compoun | 1976 |